Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways
- 1 November 2020
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 886, 173471
Abstract
No abstract availableKeywords
This publication has 189 references indexed in Scilit:
- Expression of Melatonin Synthesizing Enzymes inHelicobacter pyloriInfected Gastric MucosaBioMed Research International, 2013
- Therapeutic applications of melatoninTherapeutic Advances in Endocrinology and Metabolism, 2013
- Review of Inflammatory Bowel Disease in ChinaThe Scientific World Journal, 2013
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- The role of the Atg1/ULK1 complex in autophagy regulationCurrent Opinion in Cell Biology, 2010
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized TrialsJournal of Clinical Oncology, 2009
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Dissecting the metastatic cascadeNature Reviews Cancer, 2004
- Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinomaEuropean Journal of Cancer, 1994